TaiMed Biologics Revenue

In the year 2024, TaiMed Biologics had annual revenue of 610.16M TWD with 24.07% growth. TaiMed Biologics had revenue of 145.77M in the quarter ending December 31, 2024, a decrease of -7.87%.

Revenue

610.16M

Revenue Growth

+24.07%

P/S Ratio

39.60

Revenue / Employee

n/a

Employees

n/a

Market Cap

24.60B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	610.16M	118.39M	24.07%
Dec 31, 2023	491.78M	-71.23M	-12.65%
Dec 31, 2022	563.01M	149.57M	36.18%
Dec 31, 2021	413.44M	-309.04M	-42.78%
Dec 31, 2020	722.49M	17.98M	2.55%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	9.73B
Caliway Biopharmaceuticals	44.43M
Bora Pharmaceuticals Co., LTD.	19.25B
Lotus Pharmaceutical	18.58B
Oneness Biotech	117.93M
Lumosa Therapeutics	39.15M
Pegavision	6.82B
Polaris Group	107.00M

Revenue Rankings